Category: Clinical Studies

This blog post reviews a clinical study comparing the effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness, and neurocognitive performance in healthy volunteers, highlighting key findings and future research directions.

This blog post reviews the study on the attenuation of ketamine’s antidepressant and antisuicidal effects by opioid receptor antagonism, highlighting key findings, implications, and future research directions.

This blog post discusses the Phase 2a trial results of PCN-101 (R-ketamine) for treatment-resistant depression, highlighting key findings, patient selection criteria, safety measures, and future implications.

This blog post explores a two-site randomized controlled trial on the antidepressant efficacy of ketamine in treatment-resistant major depression, highlighting key findings, patient selection criteria, safety measures, and future implications.

This blog post explores a randomized controlled trial on the efficacy of repeated ketamine infusions for chronic PTSD. Learn about the study's key findings, patient selection criteria, safety measures, and future implications.

Ketamine therapy offers rapid antidepressant effects for treatment-resistant mood disorders. This blog post explores key findings, patient selection criteria, safety measures, and future directions, based on a consensus statement published in JAMA Psychiatry.